Category: News

  • Every bite you take, every move you make, astrocytes will be watching you

    Chewing, breathing, and other regular bodily functions that we undertake “without thinking” actually do require the involvement of our brain, but the question of how the brain programs such regular functions intrigues scientists. A team lead by Arlette Kolta, a professor at the University of Montreal’s Faculty of Dentistry, has shown that astrocytes play a

    ++++++

  • The α6 subunit of the nicotinic acetylcholine receptor determines variability in chronic pain sensitivity

    Dr. Jeffrey Mogil from McGill University led an important study published recently in Science Translational Medicine showing that expression levels of the α6 subunit of the nicotinic acetylcholine receptor (nAChR), is highly associated with allodynia, a prominent symptom of chronic pain.

    ++++++

  • How the blood-brain barrier is maintained

    A study on a protein that helps maintain the blood-brain barrier and ameliorated the effects of a multiple sclerosis-like disease in an animal model. The brain is a privileged organ in the body. So vital to life, the brain is protected from alterations elsewhere in the body by a highly regulated gateway known as the

    ++++++

  • Montréal discovery could impact the study of chronic pain conditions

    Researchers at the IRCM led by Artur Kania, Professor in the Department of Medicine at the Université de Montréal, uncovered the critical role in pain processing of a gene associated with a rare disease. Their breakthrough, published in The Journal of Neuroscience, paves the way for a better understanding of chronic pain conditions.

    ++++++

  • Researchers halt brain swelling at the source

    A team of researchers has made a significant discovery in the mechanism of brain swelling, paving the way to preventative treatment for severe to fatal brain damage following stroke, head injury or cardiac arrest. Their research, published today in Cell, paves the way for a preventative drug treatment for severe brain damage following stroke, infection,

    ++++++

  • Neuroscientists at the Hotchkiss Brain Institute find key channel in prominent inhibitory response of the brain

    Calcium ion-gated slow after-hyperpolarization (sAHP) is one of the most prominent inhibitory responses in the brain, with sAHP amplitude linked to a host of circuit and behavioral functions, yet the channel that underlies the sAHP has defied identification for decades.

    ++++++

  • Cancer drug shows promise for treating stroke

    A drug used to treat cancer may be a useful tool for improving recovery from a stroke in certain patient populations, a University of Victoria researcher has found. “A big challenge in treating stroke is understanding how other health conditions affect recovery,” says Craig Brown, a neuroscientist in UVic’s Division of Medical Sciences “Many diseases

    ++++++

  • An important scientific breakthrough by Michel Cayouette’s team in the fight against blindness

    A team of researchers at the IRCM led by Michel Cayouette, PhD, identified one of the genes responsible for producing a type of cell required for vision. The breakthrough, published in the scientific journal Neuron, could eventually help overcome obstacles associated with treatments to prevent blindness.

    ++++++

  • Smoking thins vital part of brain

    Years ago, children were warned that smoking could stunt their growth, but now a major study by an international team including the Montreal Neurological Institute at McGill University and the University of Edinburgh shows new evidence that long-term smoking could cause thinning of the brain’s cortex.

    ++++++

  • Revolutionary new probe zooms in on cancer cells

    Brain cancer patients may live longer thanks to a new cancer-detection method developed by researchers at the Montreal Neurological Institute and Hospital – The Neuro, at McGill University and the MUHC, and Polytechnique Montréal. The collaborative team has created a powerful new intraoperative probe for detecting cancer cells.

    ++++++